Oval, a collagen-based biomaterial as a sustainable alternative to leather and plastic fabrics.
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Series A PACT closed a £16 million Series A co-led by Forbion and HV Capital to scale the Oval biomaterial. | $20.3M |
| Sep 2024 | Seed Cambridge biomaterials startup PACT raised a £9M seed with Hoxton Ventures and ReGen Ventures to scale production of its collagen-based material Oval. | $11.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.